Therefore, the aim of this study was to investigate the expression level of PSMA3-AS1 and its prognostic value for PRAD, as well as the potential regulatory mechanism of PSMA3-AS1 in PRAD through the regulation of the level of miR-29a-3p. This evidence concerns the gene PSMA3 and prostate adenocarcinoma.